BCL2 and acute myeloid leukemia: Through the combination of the three technological factors of optimized lysis protocol, anti-fouling PEG layer and direct single-molecule counting, we achieved statistically significant counts for endogenous BCL2-BIM or BCL2-BAX CPXs using only ~30,000 AML cells (Fig. 1g,h).